Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

References

Page 1

	Year	Citations
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations Deborah J. Thompson, Richard S. Houlston, Catherine Phelan Nature Genetics Breast OncologyMedicineBrca2 MutationsPathologyCancer Genomics	2002	1.1K
Contralateral Breast Cancer in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Kelly Metcalfe, Henry T. Lynch, Parviz Ghadirian, Journal of Clinical Oncology	2004	616
CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 Studies The American Journal of Human Genetics Breast OncologyOncologyCancer EpidemiologyCancer RiskMedicine	2004	471
Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy in <i>BRCA1/2</i>-Associated Stage I/II Breast Cancer Lori J. Pierce, Albert M. Levin, Timothy R. Rebbeck, Journal of Clinical Oncology	2006	335
Contralateral Breast Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Monika Graeser, Christoph Engel, Kerstin Rhiem, Journal of Clinical Oncology	2009	309
Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status Bruce G. Haffty, Elizabeth V. Harrold, Atif J. Khan, The Lancet Surgical OncologyBreast OncologyEarly-onset Breast CancerMedicineCancer Management	2002	305
Risk of Breast Cancer in Women With a <i>CHEK2</i> Mutation With and Without a Family History of Breast Cancer Cezary Cybulski, Dominika Wokołorczyk, Anna Jakubowska, Journal of Clinical Oncology	2011	252
Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age Dorina M. van der Kolk, Geertruida H. de Bock, Beike Leegte, Breast Cancer Research and Treatment Breast OncologyCancer RiskCancer EpidemiologyMedicineGynecology	2010	187
<i>CHEK2</i>*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death, Breast Cancer–Specific Death, and Increased Risk of a Second Breast Cancer Maren Weischer, Børge G. Nordestgaard, Paul D.P. Pharoah, Journal of Clinical Oncology	2012	175
Survival and prognostic factors in BRCA1-associated breast cancer Cecile T.M. Brekelmans, Caroline Seynaeve, M. Menke-Pluymers, Annals of Oncology Breast OncologyMedicinePathologyBreast CancerBrca1-associated Breast Cancer	2005	134

Page 1